Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos
(MedPage Today) -- Xenon Pharmaceuticals said it paused enrollment in its major depressive disorder and bipolar depression trials after unexpected neuropsychiatric adverse events emerged. Many mental health and suicide risk indicators among youth...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.